-
Impact Of Bromocriptine On Clinical Outcomes For Peripartum Cardiomyopathy
Jacksonville, FL; Rochester, MN
The purpose of this study is to evaluate the impact of bromocriptine on myocardial recovery and clinical outcomes in women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum. Given that bromocriptine prevents breastfeeding, women with peripartum cardiomyopathy will be excluded from the trial due to a desire to continue breastfeeding but meeting all other entry criteria will be followed in an observational cohort.
-
Cardiac Troponin Fragments in Peripartum Cardiomyopathy
Rochester, MN
The primary aim of this study is to measure cardiac troponin (cTn) values with high sensitivity assays in patients with acute peripartum cardiomyopathy (PPCM) in order to determine whether specific fragments exist in these patients. We will also determine whether cTn fragment profile correlates with left ventricular recovery. Finally, we aim to establish a Bio bank in order to facilitate further investigations.
-
Screening for PPCM Using AI
Jacksonville, FL; Rochester, MN
The overall goal of this study is to investigate the use of artificial intelligence (AI) techniques as a screening tool for cardiomyopathies in pregnancy and the post-partum period.